Skip to main content
31°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mersana Therapeutics Inc
(NQ:
MRSN
)
1.820
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19
Open
1.820
Bid (Size)
1.820 (2)
Ask (Size)
2.020 (1)
Prev. Close
1.820
Today's Range
1.820 - 1.820
52wk Range
1.150 - 6.280
Shares Outstanding
71,761,525
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
October 10, 2024
Via
Benzinga
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-19.82%
-19.82%
1 Month
-14.15%
-14.15%
3 Month
+16.67%
+16.67%
6 Month
-48.00%
-48.00%
1 Year
+30.94%
+30.94%
More News
Read More
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 15, 2024
Via
Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
February 29, 2024
Via
Benzinga
A Preview Of Mersana Therapeutics's Earnings
February 27, 2024
Via
Benzinga
What To Know About Citigroup's Upgrade of Mersana Therapeutics
December 04, 2023
Via
Benzinga
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 24, 2024
Via
Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
February 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
A Preview Of Mersana Therapeutics's Earnings
November 06, 2023
Via
Benzinga
Why Mersana Therapeutics Stock Is Plunging Today?
July 27, 2023
Via
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Via
Benzinga
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
January 22, 2024
Via
InvestorPlace
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 18, 2024
Via
Benzinga
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via
PressReach
How To Invest In The Healthcare Sector
August 19, 2023
Via
Talk Markets
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 28, 2023
Via
Benzinga
Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
July 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
July 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Via
Benzinga
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
July 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.